UB Paderborn / Katalog / Suche / in CDI

Immunological Effects of Treatment with STG320 Sublingual Tablets of House Dust Mite Allergen Extracts in Subjects with HDM-Associated Allergic Asthma

Journal of allergy and clinical immunology, 2016-02, Vol.137 (2), p.AB404-AB404

2016

Link zum Volltext

Verfügbarkeit prüfen

Safety of STG320 Sublingual Tablets of House Dust Mite Allergen Extracts in Subjects with HDM-Associated Allergic Rhinitis: Results of a Pooled Analysis

Journal of allergy and clinical immunology, 2016-02, Vol.137 (2), p.AB403-AB403

2016

Link zum Volltext

Verfügbarkeit prüfen

Physician-Patient Communication Concerning Allergen Immunotherapy: Impact on Treatment Acceptance and Compliance

Journal of allergy and clinical immunology, 2015-02, Vol.135 (2), p.AB51-AB51

2015

Link zum Volltext

Verfügbarkeit prüfen

The HDM Slit-Tablet Reduces Symptoms of House Dust Mite Allergic Rhinitis Independently of Asthma Status and Allergen Sensitisation Type; A Subgroup Analysis of Results from a Dbpc Phase III Trial (MERIT)

Journal of allergy and clinical immunology, 2015-02, Vol.135 (2), p.AB268-AB268

2015

Link zum Volltext

Verfügbarkeit prüfen

Treatment with STG320 Sublingual Tablets of House Dust Mite Allergen Extracts: Profile of Subjects with HDM-Associated Allergic Rhinitis in the Clinical Development Program

Journal of allergy and clinical immunology, 2016-02, Vol.137 (2), p.AB163-AB163

2016

Link zum Volltext

Verfügbarkeit prüfen

Eassi Survey: European Multicentre Prospective Study to Collect Systemic Adverse Reactions Due to Allergen Immunotherapy: Pediatric Population Results

Journal of allergy and clinical immunology, 2016-02, Vol.137 (2), p.AB404-AB404

2016

Link zum Volltext

Verfügbarkeit prüfen

Effect of House Dust Mite SLIT-tablet Treatment on Quality of Sleep in Allergic Rhinitis Patients

Journal of allergy and clinical immunology, 2019-02, Vol.143 (2), p.AB286-AB286

2019

Link zum Volltext

Verfügbarkeit prüfen

Immunological Markers In House Dust Mite Allergic Subjects Treated With 300IR House Dust Mite Sublingual Tablets: Results From Two Phase III Trials

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB204-AB204

2018

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of the SQ HDM SLIT-tablet on House Dust Mite Induced Allergic Conjunctivitis

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB274-AB274

2018

Link zum Volltext

Verfügbarkeit prüfen

Onset of Action of Sublingual Tablets of House Dust Mite Allergen Extracts in Adults

Journal of allergy and clinical immunology, 2013-02, Vol.131 (2), p.AB37-AB37

2013

Link zum Volltext

Verfügbarkeit prüfen

IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper

The World Allergy Organization journal, 2020-02, Vol.13 (2), p.100080, Article 100080

2020

Link zum Volltext

Verfügbarkeit prüfen

Respiratory allergy caused by house dust mites: What do we really know?

Journal of allergy and clinical immunology, 2015-07, Vol.136 (1), p.38-48

2015

Link zum Volltext

Verfügbarkeit prüfen

Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report

Journal of allergy and clinical immunology, 2013-05, Vol.131 (5), p.1288-1296.e3

2013

Link zum Volltext

Verfügbarkeit prüfen

Effective treatment of house dust mite–induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial

Journal of allergy and clinical immunology, 2016-02, Vol.137 (2), p.444-451.e8

2016

Link zum Volltext

Verfügbarkeit prüfen

International consensus on allergy immunotherapy

Journal of allergy and clinical immunology, 2015-09, Vol.136 (3), p.556-568

2015

Link zum Volltext

Verfügbarkeit prüfen

An evidence-based analysis of house dust mite allergen immunotherapy: A call for more rigorous clinical studies

Journal of allergy and clinical immunology, 2013-12, Vol.132 (6), p.1322-1336

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis

Journal of allergy and clinical immunology, 2014-06, Vol.133 (6), p.1608-1614.e6

2014

Link zum Volltext

Verfügbarkeit prüfen

Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: Looking at the published evidence

Journal of allergy and clinical immunology, 2012-04, Vol.129 (4), p.929-934

2012

Link zum Volltext

Verfügbarkeit prüfen

Allergen-specific immunotherapy for respiratory allergies: From meta-analysis to registration and beyond

Journal of allergy and clinical immunology, 2011-01, Vol.127 (1), p.30-38

2011

Link zum Volltext

Verfügbarkeit prüfen

Guideline recommendations on the use of allergen immunotherapy in house dust mite allergy: time for a change?

Journal of allergy and clinical immunology, 2017-07, Vol.140 (1), p.41-52

2017

Link zum Volltext

Verfügbarkeit prüfen

MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

Journal of allergy and clinical immunology, 2016-08, Vol.138 (2), p.367-374.e2

2016

Link zum Volltext

Verfügbarkeit prüfen

Respiratory allergic diseases and allergen immunotherapy: A French patient survey before and during the COVID-19 pandemic

The World Allergy Organization journal, 2024-04, Vol.17 (4), p.100902-100902, Article 100902

2024

Link zum Volltext

Verfügbarkeit prüfen

Safety of intranasal corticosteroids in acute rhinosinusitis

American journal of otolaryngology, 2008-11, Vol.29 (6), p.403-413

Demoly, Pascal, MD

2008

Link zum Volltext

Verfügbarkeit prüfen

Criteria used by health professionals on the selection of allergen immunotherapy in real clinical practice: Methodology

The World Allergy Organization journal, 2023-02, Vol.16 (2), p.100749-100749, Article 100749

2023

Link zum Volltext

Verfügbarkeit prüfen

Allergic Rhinitis Increases the Risk of Driving Accidents

Journal of allergy and clinical immunology, 2017-08, Vol.140 (2), p.614-616

2017

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Immunological Effects of Treatment with STG320 Sublingual Tablets of House Dust Mite Allergen Extracts in Subjects with HDM-Associated Allergic Asthma

Safety of STG320 Sublingual Tablets of House Dust Mite Allergen Extracts in Subjects with HDM-Associated Allergic Rhinitis: Results of a Pooled Analysis

Physician-Patient Communication Concerning Allergen Immunotherapy: Impact on Treatment Acceptance and Compliance

The HDM Slit-Tablet Reduces Symptoms of House Dust Mite Allergic Rhinitis Independently of Asthma Status and Allergen Sensitisation Type; A Subgroup Analysis of Results from a Dbpc Phase III Trial (MERIT)

Treatment with STG320 Sublingual Tablets of House Dust Mite Allergen Extracts: Profile of Subjects with HDM-Associated Allergic Rhinitis in the Clinical Development Program

Eassi Survey: European Multicentre Prospective Study to Collect Systemic Adverse Reactions Due to Allergen Immunotherapy: Pediatric Population Results

Effect of House Dust Mite SLIT-tablet Treatment on Quality of Sleep in Allergic Rhinitis Patients

Immunological Markers In House Dust Mite Allergic Subjects Treated With 300IR House Dust Mite Sublingual Tablets: Results From Two Phase III Trials

Efficacy of the SQ HDM SLIT-tablet on House Dust Mite Induced Allergic Conjunctivitis

Onset of Action of Sublingual Tablets of House Dust Mite Allergen Extracts in Adults

IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper

Respiratory allergy caused by house dust mites: What do we really know?

Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report

Effective treatment of house dust mite–induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial

International consensus on allergy immunotherapy

An evidence-based analysis of house dust mite allergen immunotherapy: A call for more rigorous clinical studies

Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis

Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: Looking at the published evidence

Allergen-specific immunotherapy for respiratory allergies: From meta-analysis to registration and beyond

Guideline recommendations on the use of allergen immunotherapy in house dust mite allergy: time for a change?

MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

Respiratory allergic diseases and allergen immunotherapy: A French patient survey before and during the COVID-19 pandemic

Safety of intranasal corticosteroids in acute rhinosinusitis

Criteria used by health professionals on the selection of allergen immunotherapy in real clinical practice: Methodology

Allergic Rhinitis Increases the Risk of Driving Accidents

Suchergebnisse filtern